IDiyas

For the Inventor, By the Inventor

Budapest, Hungary

Tamas Hamori

USPTO Granted Patents = 17

Average Co-Inventor Count = 11.2

ph-index = 6

Forward Citations = 160(Granted Patents)


Company Filing History:

goldMedal4 out of 46 
 
Egis Gyogyszergyar
 patents
silverMedal3 out of 33 
 
Egis Gyogyszergyar Rt.
 patents
bronzeMedal2 out of 13 
 
Gyogyszerkutato Intezet Kft.
 patents
4. 2 out of 1,384 
 
Schering Aktiengesellschaft
 patents
5. 1 out of 6 
 
Gyogyszerkutato Intezet
 patents
6. 1 out of 59 
 
Egyt Gyogyszervegyeszeti Gyar
 patents
7. 1 out of 19 
 
Biogal Gyogyszergyar
 patents
8. 1 out of 1 
 
Cyogyszerkutato Intezet Kft
 patent
9. 1 out of 1 
 
Gyogyszerkutato Intezet Kv.
 patent
10. 1 out of 1 
 
Gis Gyogyszergyar Rt.
 patent

Years Active: 1983-2003

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6600036 - Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors (2003-07-29),
2. 6075018 - 1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine (2000-06-13),
3. 5942506 - 1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives (1999-08-24),
4. 5807851 - 2,3-Benzodiazepine Derivatives as non-competitive AMPA (1998-09-15),
5. 5756495 - 3-substituted 3H-2, 3-benzodiazepine derivatives, the production and use (1998-05-26),
6. 5639751 - N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic (1997-06-17),
7. 5536832 - N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions (1996-07-16),
8. 5521174 - N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of (1996-05-28),
9. 5519019 - N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions (1996-05-21),
10. 5459137 - N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions (1995-10-17),
11. 5288863 - Process for the preparation of high-purity (1994-02-22),
12. 5204343 - 5H-benzodiazepin derivative (1993-04-20),
13. 4840948 - 1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical (1989-06-20),
14. 4835152 - 1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-b (1989-05-30),
15. 4785104 - 3-(hydroxymethyl)-isoquinoline derivatives (1988-11-15),

Title: Tamas Hamori: Innovator in Pharmaceutical Chemistry

Introduction

Tamas Hamori is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that affect the central nervous system. With a total of 17 patents to his name, Hamori's work has the potential to impact therapeutic practices.

Latest Patents

Among his latest patents, Hamori has developed condensed 2,3-benzodiazepine derivatives that serve as AMPA-receptor inhibitors. These compounds, described by the formula I, are produced and utilized in pharmaceutical agents. Another significant invention is the 1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives. This invention includes a process for their preparation and pharmaceutical compositions that comprise these new derivatives. The compounds are designed to affect the central nervous system and can be advantageous in therapeutic applications.

Career Highlights

Throughout his career, Tamas Hamori has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár and Egis Gyógyszergyár Rt. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Hamori has collaborated with notable colleagues such as Ferenc Andrasi and Imre Moravcsik. Their combined expertise has contributed to the advancement of pharmaceutical research and development.

Conclusion

Tamas Hamori's contributions to pharmaceutical chemistry through his numerous patents highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…